47 Rue Adrienne Bolland
Ncardia collaborates to excel
ACEA Biosciences is a pioneer in the development of high performance cell analysis platforms for life science research. ACEA’s xCELLigence® Real-Time Cell Analysis (RTCA) instruments and NovoCyte® flow cytometer are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. The xCELLigence CardioECR system is the first instrument to simultaneously monitor integrated ion channel activity, contractility and viability of cardiomyocytes enabling predictive assays for safety/toxicity assessment as well as cardiac drug discovery. Moreover, the powerful electrical pacing functionality of the CardioECR system allows for short term and chronic pacing regimens providing assessment of compounds at different beating frequencies in addition to conditioning and maturing the cardiomyocytes for assessment of inotropic compounds.
The Maestro Pro™ and Edge™, designed by Axion BioSystems, are the world’s most powerful microelectrode array (MEA) systems. Record networks of electrically active cells (e.g. neurons, cardiac cells, and muscle cells) in a multiwell plate in real-time. Over minutes or months, gain unprecedented access to electrical network function from cultured cell populations. Perfect for characterizing hiPSC-models, researching the behavior of diseased cells, screening for drugs to treat that disease, or examining potential toxic effects of drug candidates, the Maestro platform delivers an easy-to-use, compact cellular analysis system suitable for any lab.
Hamamatsu Photonics is a leading manufacturer of optoelectronics, providing solutions for a wide range of applications including drug screening and assay development. Their light sources and detectors are integrated in a wide range of high quality instrumentation used daily in laboratories across the world. You are invited to discover the FDSS (Functional Drug Screening System) screening range and its applications for research, assay development and high throughput screening. All of Hamamatsu's systems include one or multiple injection heads which can be used with different plate formats. The modularity of the systems makes each one completely unique and their adaptability ensures they will evolve with customers' changing needs.
NANION TECHNOLOGIES is a leading provider of automated patch clamp (APC) electrophysiology systems with throughput capabilities ranging from a single cell up to fully automated high throughput screening (HTS) instruments recording from 768 cells simultaneously. Founded in 2002, Nanion has expanded its product range over the years to include in vitro systems for membrane pump and transporter recordings, bilayer recordings, and contractility measurements (impedance) from beating monolayers of cells, e.g. induced pluripotent stem cell-derived cardiac myocytes (iPSC-CMs), and confluency measurements of, e.g. hepatocytes for hepatotox screening using impedance. Nanion’s instruments combine high performance with user-friendly interfaces making them an ideal choice for academia, biotechnology, CROs and the Pharma industry.
Sophion Bioscience, a leader in the automated patch clamp field, helps drug discovery companies make more and better drugs, faster. Sophion provide integrated solutions for automated patch clamping and the two product families QPatch and Qube provide high-quality patch clamp data for industrial research, focused on unattended operation and ease of use, ensuring high laboratory efficiency and rapid turnaround time to results. Sophion Bioscience is headquartered in Copenhagen, Denmark and has subsidiaries in Boston, Tokyo and Shanghai, as well as distributors in Japan, India and Korea.